Creso Pharma Ltd (ASX: CPH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Creso Pharma Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $132.17 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 1.20 billion
Earnings per share -0.019
Dividend per share N/A
Year To Date Return -36.11%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Creso Pharma Ltd (ASX: CPH)
Latest News

CPH ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Creso Pharma Ltd

Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel and Australia. The company derives prime revenue from the Europe andMiddle East regions.

CPH Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
21 Sep 2021 $0.11 $-0.01 -8.70% 6,209,305 $0.11 $0.12 $0.11
20 Sep 2021 $0.12 $0.00 0.00% 8,072,533 $0.12 $0.13 $0.12
17 Sep 2021 $0.12 $0.00 0.00% 7,381,027 $0.12 $0.13 $0.12
16 Sep 2021 $0.12 $0.00 0.00% 4,443,604 $0.12 $0.13 $0.12
15 Sep 2021 $0.12 $0.00 0.00% 3,052,294 $0.13 $0.13 $0.12
14 Sep 2021 $0.12 $0.00 0.00% 2,467,225 $0.12 $0.13 $0.12
13 Sep 2021 $0.12 $-0.01 -8.00% 2,454,010 $0.13 $0.13 $0.12
10 Sep 2021 $0.13 $0.00 0.00% 5,629,016 $0.13 $0.13 $0.12
09 Sep 2021 $0.13 $0.00 0.00% 6,331,457 $0.13 $0.13 $0.13
08 Sep 2021 $0.13 $0.00 0.00% 2,818,627 $0.13 $0.13 $0.13
07 Sep 2021 $0.13 $0.00 0.00% 3,031,803 $0.13 $0.14 $0.13
06 Sep 2021 $0.13 $0.00 0.00% 3,308,489 $0.13 $0.13 $0.13
03 Sep 2021 $0.13 $-0.01 -7.69% 1,983,080 $0.13 $0.13 $0.13
02 Sep 2021 $0.13 $0.00 0.00% 2,968,670 $0.13 $0.14 $0.13
01 Sep 2021 $0.13 $0.00 0.00% 3,955,483 $0.14 $0.14 $0.13
31 Aug 2021 $0.13 $0.01 8.33% 16,364,583 $0.14 $0.14 $0.13
30 Aug 2021 $0.12 $0.00 0.00% 518,406 $0.12 $0.13 $0.12
27 Aug 2021 $0.12 $0.00 0.00% 2,047,289 $0.13 $0.13 $0.12
26 Aug 2021 $0.12 $-0.01 -8.00% 3,441,549 $0.13 $0.13 $0.12
25 Aug 2021 $0.13 $0.00 0.00% 2,063,528 $0.13 $0.13 $0.12
24 Aug 2021 $0.13 $0.00 0.00% 5,638,139 $0.13 $0.13 $0.12

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
14 Jul 2021 Adam Blumenthal Issued 12 $1,560,000
Issue of securities.
14 Jul 2021 James Ellingford Issued 500 $65,000
Issue of securities.
14 Jul 2021 Boaz Wachtel Issued 500 $65,000
Issue of securities.
07 Jul 2021 Adam Blumenthal Sell 87 $7,903,077
Off-market trade.
07 Jul 2021 Adam Blumenthal Sell 32 $4,493,912
On-market trade.
09 Mar 2021 James Ellingford Transfer 797 $159,500
Off-market transfer.
22 Jan 2021 Adam Blumenthal Issued 87 $18,879,575
Issue of securities. As per announcement on 27/01/2021.
23 Dec 2020 Adam Blumenthal Issued 137 $4,000,000
Placement.
12 Oct 2020 Adam Blumenthal Issued 833 $49,999
Placement.
12 Oct 2020 Miriam Wernli Issued 833 $49,999
Placement.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Adam Blumenthal Non-Executive DirectorNon-Executive Chairman Nov 2015
Mr Blumenthal has over 10 years experience in Investment Banking and Corporate Finance. He has exposure to Australian and International markets, having provided capital raising and financing solutions to an number of unlisted and listed companies. Adam has played a lead role in advising and supporting multiple organisations across a broad spectrum of industries, using his experience and network of international contacts to provide corporate advisory and capital markets input. He has successfully brought to market several Medical Marijuana companies spanning Israel, Canada, Switzerland and Australia. He has also been actively involved in the Mining, Cyber Security, Health Care and IT sectors. Adam is a director of EverBlu Capital Pty Ltd, the Company's appointed corporate advisor and lead manager to the various capital raisings undertaken by the Company in CY2020. Outside of his formal business activities, Adam has lectured at a leading Sydney University covering corporate governance, corporate social responsibility and ASX listings - both at an undergraduate and postgraduate level. He is a member of the Israel Business Club Sydney (IBCS).
Dr James Anthony Ellingford Executive Director Nov 2015
Dr Ellingford has vast experience in the international arena and has successfully developed close ties with both financial institutions as well as governments throughout the world. Dr Ellingford's professional life culminated in being President of an international publicly listed billion-dollar business with its headquarters in Geneva, Switzerland and New York, USA. Dr Ellingford used to lecture MBA students in Corporate Governance at a leading Sydney University and has a keen interest in ethics. Dr Ellingford is chairman of Risk Committee.
Mr Boaz Wachtel Non-Executive Director Nov 2015
Mr Wachtel was Co-Founder and former Managing Director of MMJ-PhytoTech Ltd, Australia's first publicly traded Medical Cannabis Company. Co-founder of IMCPC - International Medical Cannabis Patient Coalition. He is an Israeli medical cannabis pioneer/activist, who formulated and assisted the Ministry of Health with the implementation of the National Medical Cannabis Program - one of only few national programs in the world. He is a frequent lecturer and adviser to governments, national committees, business and NGO's on medical cannabis program formulation, grow operations, international laws and UN drug convention compliance, as well as the founder (1999) and former Chairman of the Green Leaf Party, an Israeli political party for cannabis legalisation/medicalisation, human rights and ecology. Mr Wachtel is member of Risk Committee.
Mr Winton William Willesee Joint Company Secretary Oct 2018
-
Ms Erlyn Dale Joint Company Secretary Oct 2018
-
Christopher Grundy Chief Financial Officer
-
Winton William Willesee Joint Company Secretary
-
Erlyn Dale Joint Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Atlantic Capital Holdings Pty <Atlantic Capital A/C> 139,415,432 14.62%
Hsbc Custody Nominees (Australia) Limited 33,358,651 3.50%
Suburban Holdings Pty Ltd<The Suburban Super Fund A/C> 27,507,750 2.88%
Jamber Investments Pty Ltd <The Amber Schwarz Fam A/C> 20,200,000 2.12%
Citicorp Nominees Pty Limited 19,026,497 2.00%
Mr William James Fleming 16,600,000 1.74%
Miriam Halperin Wernli 13,333,333 1.40%
J P Morgan Nominees Australia Pty Limited 8,764,097 0.92%
International Water & Energy Savers Ltd 8,300,000 0.87%
RS Family Holdings Pty Ltd <The Ruth Simon Family A/C> 8,158,803 0.86%
Anglo Australasia Holdings Pty Ltd <Anglo Australasia A/C> 7,083,333 0.74%
Mr Lisheng Wang 5,050,000 0.53%
Mr Kenneth Joseph Hall <Hall Park A/C> 5,000,000 0.52%
Chincherinchee Nominees Pty Ltd 4,436,427 0.47%
S3 Consortium Holdings Pty Ltd <Nextinvestors Dot Com A/C> 4,300,000 0.45%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 4,205,098 0.44%
Tenorio Pty Limited <Tenorio A/C> 3,581,427 0.38%
Mr Matthew Clarke Mallet 3,400,000 0.36%
Ubs Nominees Pty Ltd 3,192,251 0.33%
Comsec Nominees Pty Limited 3,176,508 0.33%

Profile

since

Note